Table of Contents
ISRN Ophthalmology
Volume 2012 (2012), Article ID 267643, 10 pages
http://dx.doi.org/10.5402/2012/267643
Clinical Study

Triamcinolone and Bevacizumab as Adjunctive Therapies to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

1Ophthalmology Department, University Hospital Complex, Ramon Baltar s/n, 15706 Santiago de Compostela, Spain
2Gomez-Ulla Institute of Ophthalmology, Avenida de las Burgas 2, HNS de la Esperanza, 15705 Santiago de Compostela, Spain
3Ophthalmology Department, Bellvitge University Hospital, Avenida Granvia s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain

Received 27 August 2012; Accepted 8 October 2012

Academic Editors: T. Mimura, M. Nakazawa, and L. Pierro

Copyright © 2012 F. Lopez-Lopez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kempen, B. O'Colmain, and M. Leske, “The prevalence of diabetic retinopathy among adults in the United States,” Archives of Ophthalmology, vol. 122, p. 12, 2004. View at Google Scholar
  2. R. Klein, B. E. K. Klein, and S. E. Moss, “The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years,” Archives of Ophthalmology, vol. 102, no. 4, pp. 520–526, 1984. View at Google Scholar · View at Scopus
  3. R. Klein, B. E. K. Klein, and S. E. Moss, “The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years,” Archives of Ophthalmology, vol. 102, no. 4, pp. 527–532, 1984. View at Google Scholar · View at Scopus
  4. A. P. Adamis, J. W. Miller, M. T. Bernal et al., “Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 118, no. 4, pp. 445–450, 1994. View at Google Scholar · View at Scopus
  5. L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Pe'er, D. Shweiki, A. Itin, I. Hemo, H. Gnessin, and E. Keshet, “Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases,” Laboratory Investigation, vol. 72, no. 6, pp. 638–645, 1995. View at Google Scholar · View at Scopus
  7. The Diabetic Retinopathy Study Research Group, “Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8,” Ophthalmology, vol. 88, no. 7, pp. 583–600, 1981. View at Google Scholar · View at Scopus
  8. D. N. Zacks and M. W. Johnson, “Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy,” Retina, vol. 25, no. 2, pp. 135–140, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Bandello, A. Polito, D. R. Pognuz, P. Monaco, A. Dimastrogiovanni, and J. Paissios, “Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 124, no. 5, pp. 643–650, 2006. View at Google Scholar · View at Scopus
  10. W. M. Zein, B. N. Noureddin, F. A. Jurdi, A. Schakal, and Z. F. Bashshur, “Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema,” Retina, vol. 26, no. 2, pp. 137–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. R. F. Spaide and Y. L. Fisher, “Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage,” Retina, vol. 26, no. 3, pp. 275–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. O. Mason, P. A. Nixon, and M. F. White, “Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 142, no. 4, pp. 685–688, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mirshahi, R. Roohipoor, A. Lashay, S. F. Mohammadi, A. Abdoallahi, and H. Faghihi, “Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial,” European Journal of Ophthalmology, vol. 18, no. 2, pp. 263–269, 2008. View at Google Scholar · View at Scopus
  14. M. Tonello, R. A. Costa, F. P. P. Almeida, J. C. Barbosa, I. U. Scott, and R. Jorge, “Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study),” Acta Ophthalmologica, vol. 86, no. 4, pp. 385–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. M. Minnella, C. M. Savastano, L. Ziccardi et al., “Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy,” Acta Ophthalmologica, vol. 86, no. 6, pp. 683–687, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. B. H. Doft and G. Blankenship, “Retinopathy risk factor regression after laser panretinal photocoagulation for proliferative diabetic retinopathy,” Ophthalmology, vol. 91, no. 12, pp. 1453–1457, 1984. View at Google Scholar · View at Scopus
  17. J. F. Vander, J. S. Duker, W. E. Benson, G. C. Brown, J. A. McNamara, and R. B. Rosenstein, “Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation,” Ophthalmology, vol. 98, no. 10, pp. 1575–1579, 1991. View at Google Scholar · View at Scopus
  18. V. M. Reddy, R. L. Zamora, and R. J. Olk, “Quantitation of retinal ablation in proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 119, no. 6, pp. 760–766, 1995. View at Google Scholar · View at Scopus
  19. W. B. Cho, S. B. Oh, J. W. Moon, and H. C. Kim, “Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy,” Retina, vol. 29, no. 4, pp. 516–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. Early Treatment Diabetic Retinopathy Study Research Group, “Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12,” Ophthalmology, vol. 98, no. 5, supplement, pp. 823–833, 1991. View at Google Scholar
  21. “Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics: ETDRS report number 7,” Ophthalmology, vol. 98, no. 5, supplement, pp. 741–756, 1991.
  22. L. T. Chylack, J. K. Wolfe, D. M. Singer et al., “The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group,” Archives of Ophthalmology, vol. 111, no. 6, pp. 831–836, 1993. View at Google Scholar · View at Scopus
  23. T. W. Gardner, A. W. Eller, and T. R. Friberg, “Reduction of severe macular edema in eyes with poor vision after panretinal photocoagulation for proliferative diabetetic retinopathy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 229, no. 4, pp. 323–328, 1991. View at Google Scholar · View at Scopus
  24. H. R. McDonald and H. Schatz, “Macular edema following panretinal photocoagulation,” Retina, vol. 5, no. 1, pp. 5–10, 1985. View at Google Scholar · View at Scopus
  25. H. R. McDonald and H. Schatz, “Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy,” Ophthalmology, vol. 92, no. 3, pp. 388–393, 1985. View at Google Scholar · View at Scopus
  26. U. H. M. Spandau, M. Derse, P. Schmitz-Valckenberg, C. Papoulis, and J. B. Jonas, “Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema,” British Journal of Ophthalmology, vol. 89, no. 8, pp. 999–1003, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. G. A. Lalwani, P. J. Rosenfeld, A. E. Fung et al., “A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study,” American Journal of Ophthalmology, vol. 148, no. 1, pp. 43.e1–58.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Brucker, H. Qin, A. N. Antoszyk et al., “Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings,” Archives of Ophthalmology, vol. 127, no. 2, pp. 132–140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. K. S. Choi, J. K. Chung, and S. H. Lim, “Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema,” Korean Journal of Ophthalmology, vol. 21, no. 1, pp. 11–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. W. B. Cho, J. W. Moon, and H. C. Kim, “Intravitreal triamcinolone and bevacizumab as adjunctive treatments to panretinal photocoagulation in diabetic retinopathy,” British Journal of Ophthalmology, vol. 94, no. 7, pp. 858–863, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. O. O. Maia, B. S. Takahashi, R. A. Costa, I. U. Scott, and W. Y. Takahashi, “Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial,” American Journal of Ophthalmology, vol. 147, no. 2, pp. 291–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. Kim, J. S. Pollack, D. G. Miller, R. A. Mittra, and R. F. Spaide, “ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema,” Retina, vol. 28, no. 5, pp. 735–740, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Funatsu, H. Noma, T. Mimura, S. Eguchi, and S. Hori, “Association of vitreous inflammatory factors with diabetic macular edema,” Ophthalmology, vol. 116, no. 1, pp. 73–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. G. W. Blankenship, “Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study,” Ophthalmology, vol. 98, no. 2, pp. 125–128, 1991. View at Google Scholar · View at Scopus